This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.
In this episode, I’ll discuss a tip to predict pharmacotherapy needs in rapid response or emergent situations. Episode 973: A tip for predicting the pharmacotherapy needs of your patient in rapid response or emergent situations Subscribe on iTunes , Android , or Stitcher At the beginning of any rapid response or emergent procedure such as rapid sequence intubation, make a note of your patient’s starting heart rate, rhythm, oxygen saturation, and blood pressure.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It would stay quiet for a bit, but then the beeping would start again, telling Tammy Clemons over and over that she was back in the emergency room. She wished she were elsewhere. She wished she were with her sister, who’d just had a stillborn baby in a different hospital, three miles away.
Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information from medical images and combine it with epidemiological, clinical, and genomic data, has completed a $34 million Series B financing.
Are you gearing up for the BCPS exam in 2025 and looking for the best resources to help you succeed? We’ve got some exciting news that will make your preparation easier and more affordable! For a limited time, we’re offering $100 OFF our comprehensive BCPS Exam Study Materials (1 Year All Access Pass), designed by […] The post 2025 BCPS Study Materials $100 Discount AND FREE Audible Book!
Lupin, a global pharmaceutical company, has announced its tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. The approval enables Lupin to market a generic equivalent of Isentress HD Tablets, 600 mg, produced by Merck Sharp & Dohme LLC. Lupin is the exclusive first-to-file applicant for this product, potentially granting it a 180-day exclusivity period in the U.S. market.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Introduction A hiccup occurs due to an involuntary, intermittent, spasmodic contraction of the diaphragm and intercostal muscles. Although hiccups most commonly are self-limited (last for 48 hours are classified as persistent, while those lasting >1 month are considered intractable. Management Treatment of hiccups should be focused on the underlying cause when possible.
RPG Life Sciences announced that Managing Director Yugal Sikri will retire on April 30, 2025, after over six years in the role. Under Sikri’s leadership, the company saw a significant transformation, with consistent year-on-year growth across business segments and key financial indicators. RPG Life Sciences recorded a fourfold increase in EBITDA, an EBITDA margin rise of 1,290 basis points, and an eightfold growth in PAT, with a PAT margin increase of 1,180 basis points.
Introduction Compression stockings are special, snug-fitting socks used to help prevent swelling and improve blood flows in the legs. Compression stockings are recommended when you sit or stand for long periods without moving, such as during a long flight. They may also be used during pregnancy to reduce the risk of developing lower limb oedema, varicose veins and deep vein thrombosis.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
69 
Let's personalize your content